1. Investing in New Technologies for Innovative Functional Solutions

    Sarath Chandar, Chief Scientific Officer, Applied Innovation Group at SPI Pharma discusses how the company is re-engaging in innovation.

  2. Particle Engineering for Improved Bioavailability in Oral Solid Dose Medications
    Catalent’s Ronak Savla, Ph.D., Scientific Affairs Manager and Stephen Tindal, Director of Scientific Affairs, explains the OSD evolution.
  3. How do you Address Operational Excellence as an Institution?

    Industry experts weigh in on our Roundtable question.

  4. Fit Biopharmaceutical Facilities: A Predictive Maintenance Approach

    Andrew Harris, Associate, Lead Process Engineer and Joe Povenski, Process Specialist for CRB USA explain maintaining facilities.

  5. Optimizing API Production as a True Manufacturing Partner

    Jim Scandura, Executive Vice President, Chief Operating Officer at Avara Pharmaceutical Service discusses serving as a partner for API production.

  6. Analytical Testing - Contractors Take on the Challenge of Complex Molecules

    A SPECIAL FEATURE by Drug Development & Delivery.

    The global pharmaceutical analytical testing outsourcing market could reach $9.6 billion by 2025.

  7. Stem Cell Research May Lead to Treatments for Gastrointestinal Diseases

    Researchers have grown a mini esophagus from stem cells.

  8. Gene that Helps Cells Resist Zika Infection Identified

    Found by University of Texas Southwestern Medical Center researchers using CRISPR.

  9. Researchers Make Major Breakthrough in Controlling the 3D Structure of Molecules

    A team of scientists from The Graduate Center of The City University of New York has made a breakthrough in chemical synthesis that makes it possible to quickly and reliably modify a molecule's 3D structure.

  10. FDA Permits Marketing of Transcranial Magnetic Stimulation for Treatment of Obsessive Compulsive Disorder

    Transcranial magnetic stimulation (TMS) is a procedure that uses magnetic fields to stimulate nerve cells in the brain.

  11. Accelerating Approval and Reducing Costs of Spray Dried Drugs through Development by Design (DbD)

    Filipe Gaspar, Vice President, R&D and Márcio Temtem, Ph.D., Associate Director for Particle Design & Formulation at Hovione explain Development by Design (DbD).

  12. Achieving a High Level of Customer Service Through Lean Quality Management

    Warren Horton, Executive Vice President Global Quality Assurance and Regulatory at Avara Pharmaceutical Services discusses the real foundation of customer service.

  13. Differentiating Generic SODFs with Hard Capsule Formulations

    With lower development costs and greater flexibility, hard capsules are the best choice for the formulation of generic solid oral dosage pharmaceuticals, explains Jonathan Gilinski, Executive Director for CapsCanada.

  14. Innovating Equipment: Inline Buffer Dilution Technology

    Nice Insight is in conversation with Kimo Sanderson, at Asahi Kasei Bioprocess America, to discuss the company’s “technology of the decade.”

  15. Implications of Serialization for the U.S. Pharma Industry
    Lee Murtagh and Walter Hoberg III of Alcami explain the upcoming regulatory impact on the industry.
  16. Perspectives on Product Pricing Strategy and Practice
    Getting pricing “right” is a tricky balancing act, but one that offers tremendous value for all.
  17. Elysium Health™ Announces Exclusive License for Use of Nicotinamide Riboside for the Slowing of Aging and Prevention of Age-Related Diseases from Mayo Clinic and Harvard

    Aging is the single greatest risk factor for major debilitating and life-threatening conditions, including cancer, cardiovascular disease, and neurodegeneration.

  18. Patients with Rare Leukemia Disease Will Have New Treatment Option

    US FDA approves AstraZeneca’s Lumoxiti (moxetumomab pasudotox) for the treatment of patients with hairy cell leukemia (HCL) who have undergone at least two prior therapies.


  19. New Genetic Understanding Could Lead to Brain Cancer Treatments

    Researchers have identified the gene mutation that leads to the brain cancer glioblastoma


  20. Xeris Pharmaceuticals and OHSU Conducting Artificial Pancreas Clinical Trial Using Xeris’ Novel Ready-to-Use Liquid Glucagon

    Patients enrolling in Phase 1 clinical trial using Xeris’ ready-to-use liquid glucagon formulation as part of a fully integrated, dual-hormone closed-loop system.

Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
Clinical Results

Fish-Oil Drug Shows Dramatic Results in Cardiovascular Study

Sep 25, 2018 12:56:50 PM PAO-M09-18-NI-025

FDA Removes Partial Clinical Hold on Tazemetostat Clinical Trials

Sep 25, 2018 12:53:57 PM PAO-M09-18-NI-024

New Evidence Suggests the Brain and Stomach are in Direct Communication

Sep 25, 2018 12:49:56 PM PAO-M09-18-NI-023
Blood Test

New Blood Test from Roche Detects Common Gene Mutations

Sep 25, 2018 12:46:33 PM PAO-M09-18-NI-022
Drug Candidate

Cancer Drug Candidate Attracts Big Pharma Attention

Sep 25, 2018 12:41:20 PM PAO-M09-18-NI-021
Small Molecule

New Small-Molecule Drugs Could Enhance Immune Responses to Cancer

Sep 25, 2018 12:35:33 PM PAO-M09-18-NI-020

Stem Cell Research May Lead to Treatments for Gastrointestinal Diseases

Sep 25, 2018 12:32:08 PM PAO-M09-18-NI-019
Cell and Gene Therapy

Gene that Helps Cells Resist Zika Infection Identified

Sep 25, 2018 12:29:34 PM PAO-M09-18-NI-018

New Genetic Understanding Could Lead to Brain Cancer Treatments

Sep 21, 2018 10:59:39 AM PAO-M09-18-NI-017
Drug Development

Patients with Rare Leukemia Disease Will Have New Treatment Option

Sep 21, 2018 10:57:13 AM PAO-M09-18-NI-016

Allergan Makes Neurotoxin Buy with Acquisition of Bonti Inc.

Sep 19, 2018 4:15:43 PM PAO-M09-18-NI-015

J&J Anticipates Growth

Sep 19, 2018 4:07:28 PM PAO-M09-18-NI-014
  • CDMO
  • Pharma

Preparing for Hurricane Florence in Pharma

Sep 18, 2018 3:11:56 PM PAO-M09-18-NI-013
FDA Approval

Latest Apple Watch Gets FDA Approval as a Class II Device

Sep 18, 2018 2:54:20 PM PAO-M09-18-NI-012

Transforming with an Equipment Partner: Preparing the Industry for Serialization

Sep 17, 2018 6:00:00 AM PAO-M09-18-CL-001

Novartis Unloads Sandoz US Components

Sep 14, 2018 1:17:21 PM PAO-M09-18-NI-011

Ophthalmic Drug Developer Kodiak BioSciences Files for IPO

Sep 14, 2018 1:15:11 PM PAO-M09-18-NI-010

EU Gives Nod to KEYTRUDA and Chemotherapy Combination Treatment

Sep 14, 2018 1:12:10 PM PAO-M09-18-NI-009
Breakthrough Therapy

Breakthrough Therapy Designation for New Asthma Drug

Sep 13, 2018 2:38:31 PM PAO-M09-18-NI-008
Drug Development

Sanofi-Aventis Collaborates with Dyadic International on Cl Gene Expression

Sep 13, 2018 2:34:36 PM PAO-M09-18-NI-007

Nice Insight Overview

Changes in the  Biopharma Industry: from Minor to Major Evolution
New technologies such as gene editing are leading to the development of even more advanced, targeted medicines.

The Next-Generation Player

Addressing Development Challenges for Complex Biologic Drug Candidates
At Lonza, we are constantly looking to reduce the development timeline, giving our customers more control over their projects.

Karen Fallen, Vice President, Business Unit Head of Clinical Development & Manufacturing Lonza Pharma & Biotech

M+A Column

Inside Mergers & Acquisitions
Kevin Bottomley Partner, Results Healthcare
Deals in the pharmaceutical industry are an important mechanism of acquiring innovation, business and efficiency.

Nice Insight Overview

Doping: Famous Cases, Substances and Values in Sports

Marc Technow, Nice Insight